A Brief Guide to Preparing a Peptide–Drug Conjugate
Abstract: Peptide–drug conjugates (PDCs) have recently emerged as interesting hybrid constructs not only for targeted therapy, but also for the early diagnosis of different pathologies. In most cases, the crucial step in the PDC synthesis is the final conjugation step, where a specific drug is bound to a particular peptide‐/peptidomimetic‐targeting unit. Thus, this concept paper aims to give a short guide to determining the finest conjugation reaction, by considering in particular the reaction conditions, the stability of the linker and the major pros and cons of each reaction. Based on the recent PDCs reported in literature, the most common and efficient conjugation methods will be systematically presented and compared, generating a short guide to consult while planning the synthesis of a novel peptide–drug conjugate.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
A Brief Guide to Preparing a Peptide–Drug Conjugate ; day:31 ; month:07 ; year:2023 ; extent:9
ChemBioChem ; (31.07.2023) (gesamt 9)
- Creator
-
Bugatti, Kelly
- DOI
-
10.1002/cbic.202300254
- URN
-
urn:nbn:de:101:1-2023080115041089706520
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bugatti, Kelly
Other Objects (12)
Design and structural validation of peptide–drug conjugate ligands of the kappa-opioid receptor
DTX-P7, a peptide–drug conjugate, is highly effective for non-small cell lung cancer
The First FDA-Approved Antibody-Drug Conjugate
Enhanced efficacy of combined VEGFR peptide–drug conjugate and anti-PD-1 antibody in treating hepatocellular carcinoma
Ein Peptidkonjugatvakzin gegen Masern : = A peptide-conjugate vaccine against measles
Tumor Targeting with an iso DGR–Drug Conjugate
A VEGFR targeting peptide-drug conjugate (PDC) suppresses tumor angiogenesis in a TACE model for hepatocellular carcinoma therapy
Ferrocene‐Peptide Conjugate for the Detection and Quantification of Ascorbic Acid
Cell cycle dependence of apoptosis photo-triggered using peptide-photosensitizer conjugate
Project management checklists : a guide to preparing and conducting projects
Bioorthogonal CRISPR/Cas9‐Drug Conjugate: A Combinatorial Nanomedicine Platform
Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody–Drug Conjugate
Design and structural validation of peptide–drug conjugate ligands of the kappa-opioid receptor
DTX-P7, a peptide–drug conjugate, is highly effective for non-small cell lung cancer
The First FDA-Approved Antibody-Drug Conjugate
Enhanced efficacy of combined VEGFR peptide–drug conjugate and anti-PD-1 antibody in treating hepatocellular carcinoma
Ein Peptidkonjugatvakzin gegen Masern : = A peptide-conjugate vaccine against measles
Tumor Targeting with an iso DGR–Drug Conjugate
A VEGFR targeting peptide-drug conjugate (PDC) suppresses tumor angiogenesis in a TACE model for hepatocellular carcinoma therapy
Ferrocene‐Peptide Conjugate for the Detection and Quantification of Ascorbic Acid
Cell cycle dependence of apoptosis photo-triggered using peptide-photosensitizer conjugate
Project management checklists : a guide to preparing and conducting projects
Bioorthogonal CRISPR/Cas9‐Drug Conjugate: A Combinatorial Nanomedicine Platform
Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody–Drug Conjugate
Design and structural validation of peptide–drug conjugate ligands of the kappa-opioid receptor
DTX-P7, a peptide–drug conjugate, is highly effective for non-small cell lung cancer
The First FDA-Approved Antibody-Drug Conjugate
Enhanced efficacy of combined VEGFR peptide–drug conjugate and anti-PD-1 antibody in treating hepatocellular carcinoma
Ein Peptidkonjugatvakzin gegen Masern : = A peptide-conjugate vaccine against measles
Tumor Targeting with an iso DGR–Drug Conjugate
A VEGFR targeting peptide-drug conjugate (PDC) suppresses tumor angiogenesis in a TACE model for hepatocellular carcinoma therapy
Ferrocene‐Peptide Conjugate for the Detection and Quantification of Ascorbic Acid
Cell cycle dependence of apoptosis photo-triggered using peptide-photosensitizer conjugate
Project management checklists : a guide to preparing and conducting projects
Bioorthogonal CRISPR/Cas9‐Drug Conjugate: A Combinatorial Nanomedicine Platform